Needle Free Injection Systems Market worth $20.17 Billion by 2021

Needle-Free Injection System Market by Product (Fillable, Prefilled), by Technology (Jet, Spring, Laser, Vibration), Usability (Reusable, Disposable), Type of Medication (Liquid, Depot), Delivery Site (Intramuscular, Subcutaneous) - Forecasts to 2021

(EMAILWIRE.COM, September 12, 2019 ) According to the new market research report "Needle-Free Injection System Market by Product (Fillable, Prefilled), by Technology (Jet, Spring, Laser, Vibration), Usability (Reusable, Disposable), Type of Medication (Liquid, Depot), Delivery Site (Intramuscular, Subcutaneous) - Forecasts to 2021", published by MarketsandMarkets™, The global needle-free injection system market, in terms of value, is projected to reach USD 20.17 Billion by 2021 from USD 9.81 Billion in 2016, at a CAGR of 15.5% during the forecast period.

Don’t miss out on business opportunities in Needle-Free Injection System Market @https://www.marketsandmarkets.com/Market- Reports/needle-free-injection-system-market-165815861.html

Major factors driving the growth of this market include growing prevalence of chronic disease, increasing incidence of communicable disease due to needle stick injuries, rising demand for biosimilars and vaccination, advantages of drug delivery technology, increasing demand for self-injection devices. On the other hand, high development cost of needle-free injection system over the conventional needle injection may hinder the growth of this market during the forecast period.

Browse and in-depth TOC on "Needle-Free Injection System Market"

151 - Tables
33 - Figures
183 - Pages

The report segments the market based on product, technology, type, site of delivery, applications, end user and regions. Based on the technology, the market is divided into Jet-based needle-free injectors, spring-based needle-free injectors, laser-based needle-free injectors and vibration-based needle-free injectors. The jet-based needle-free injectors are expected to witness the highest growth during the forecast period, due to their advantages over the other injector systems.

Make an Inquiry Prior To Purchase this research study @https://www.marketsandmarkets.com/PressReleases/needle-free-injection-system.asp

North America is expected to dominate the market, followed by Europe. The increasing demand for self-administration, and rising prevalence of chronic diseases and conditions (such as heart disease, stroke, cancer, type 2 diabetes, obesity, and arthritis), advantages offer by needle-free injection system are driving market growth in North America.

Request Research Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=165815861